Sarasin & Partners LLP Illumina, Inc. Transaction History

Sarasin & Partners LLP

$10.6 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	SELL	$128.91 - $192.44 $16.4 Million - $24.4 Million	-126,990 Reduced 22.97%	425,788 $58.5 Million
Q2 2023 Jul 10, 2023	BUY	$183.43 - $232.67 $813,512 - $1.03 Million	4,435 Added 0.81%	552,778 $104 Million
Q1 2023 May 05, 2023	SELL	$193.75 - $232.55 $13.6 Million - $16.3 Million	-70,028 Reduced 11.32%	548,343 $128 Million
Q1 2023 Apr 27, 2023	BUY	$193.75 - $232.55 $12 Million - $14.4 Million	61,964 Added 11.14%	618,371 $144 Million
Q4 2022 Jan 30, 2023	BUY	$187.24 - $242.74 $4.29 Million - $5.56 Million	22,907 Added 4.29%	556,407 $113 Million
Q3 2022 Oct 18, 2022	SELL	$177.23 - $227.44 $18.9 Million - $24.2 Million	-106,419 Reduced 16.63%	533,500 $102 Million
Q2 2022 Jul 13, 2022	BUY	$181.58 - $368.0 $8.03 Million - $16.3 Million	44,249 Added 7.43%	639,919 $118 Million
Q1 2022 Apr 11, 2022	SELL	$303.87 - $423.8 $6.51 Million - $9.08 Million	-21,435 Reduced 3.47%	595,670 $208 Million
Q4 2021 Jan 19, 2022	BUY	$347.28 - $421.83 $79.6 Million - $96.6 Million	229,112 Added 59.05%	617,105 $235 Million
Q3 2021 Oct 22, 2021	BUY	$405.61 - $524.84 $24.7 Million - $31.9 Million	60,848 Added 18.6%	387,993 $157 Million
Q2 2021 Jul 13, 2021	BUY	$372.84 - $481.5 $39 Million - $50.3 Million	104,490 Added 46.93%	327,145 $155 Million
Q1 2021 Apr 29, 2021	BUY	$361.28 - $504.76 $12.1 Million - $16.9 Million	33,545 Added 17.74%	222,655 $85.5 Million
Q4 2020 Jan 19, 2021	BUY	$292.7 - $370.96 $3.66 Million - $4.64 Million	12,519 Added 7.09%	189,110 $70 Million
Q3 2020 Nov 09, 2020	BUY	$268.51 - $400.74 $47.4 Million - $70.8 Million	176,591 New	176,591 $54.6 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account